Dermatitis herpetiformis is a chronic autoimmune disorder associated with gluten-sensitive enteropathy. It is a rare disorder linked with celiac disease. This disease was described by Dr. Duhring in 1884, hence it is called Duhring disease or Duhring-Brocq disease. It is characterized by the formation of erythematous, urticarial plagues, blisters, and pruritic vesicles. These mostly form on the surface of knees, back, scalp, elbows, and buttocks. The disease can be extremely frustrating for some patients; however, advanced medical facilities and lifestyle modifications have made treatment of dermatitis herpetiformis possible. The incidence rate of dermatitis herpetiformis in the U.S. is nearly 11.2 people per 100,000 and 75.3 per 100,000 globally. Etiology of the disease includes different factors, genetic and autoimmune. It causes intolerance to the gliadin fraction of gluten protein found in wheat, rye, and barley. Gluten present in the diet triggers formation of immunoglobulin A antibodies which start autoimmune process against skin and gut. Gastrointestinal disorders may or may not be symptomatic in dermatitis herpetiformis. However, around 90% of affected patients who undergo endoscopic evaluation display gluten-sensitive enteropathy. Moreover, diagnosis requires skin biopsy and treatment involves mostly gluten-free diet. Dapsone provides quick relief in symptoms on the skin.
The global dermatitis herpetiformis market is driven by factors such as high unmet needs for gluten-free diet in some countries, increase in incidence of dermatitis herpetiformis, rise in research & development of new treatment options, and surge in awareness. However, high cost of gluten-free diet restrain the global dermatitis herpetiformis market.
Based on treatment, the global dermatitis herpetiformis market can be segmented into dietary (gluten-free diet) and therapeutics. Dietary treatment involves lifelong, strict gluten-free diet. The permissible limit of gluten present in gluten-free diet is 20 ppm in most of the countries; however, in some countries, 100 ppm of gluten is permitted. Gluten-free diet resolves gastrointestinal symptoms in three to six months, while cutaneous lesions takes on average one to two years of gluten-free diet for complete resolution. However, it can recur if gluten is reintroduced in the diet. Hence, high requirement of gluten-free diet for dermatitis herpetiformis patients is projected to propel the dietary (gluten-free diet) segment in the near future. Gluten-free diet is available in the form of bakery products, pasta, and also ready-to-eat meals. The therapeutics segment can be categorized into dapsone, sulfa drugs, and others. Dapsone is the first line of treatment in dermatitis herpetiformis patients; however, it has some severe side effects. Patients who cannot tolerate dapsone are prescribed sulfa drugs such as sulfasalazine, sulfapyridine, and sulfamethoxypyridazine. Other category of drugs such as topical corticosteroids are usually used to control skin symptoms of dermatitis herpetiformis.
Geographically, the global dermatitis herpetiformis market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The dermatitis herpetiformis market in North America and Europe is projected to grow at a moderate pace during the forecast period owing to rise in demand for advanced treatment, increase in health care expenditure, and surge in diagnosis rate. The dermatitis herpetiformis market in Asia Pacific is likely to grow at a faster pace due to developing health care infrastructure, increase in government expenditure on health care, and rise in the number of patients suffering from dermatitis herpetiformis.
The Kellogg Company, The Red Mill, Wendy’s, Canyon Bakehouse, Blue Diamond, and Genius Foods Pvt. Ltd. are the leading players in the gluten-free products segment.
Key players in the therapeutics segment include HBC Chem, Shingles Skincare, Anvia Chemicals, Ivy Fine Chemicals, Aidance Scientific, AlliChem, Waterstone Technology, Acros Organics, and 3B Scientific.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.